{"id":"https://openalex.org/W65134806","doi":"https://doi.org/10.1111/j.1464-410x.2011.10124.x","title":"Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4\u2010year results from the randomized, double\u2010blind Combination of Avodart and Tamsulosin (CombAT) trial","display_name":"Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4\u2010year results from the randomized, double\u2010blind Combination of Avodart and Tamsulosin (CombAT) trial","alternate_titles":[],"publication_year":2011,"publication_date":"2011-02-18","ids":{"openalex":"https://openalex.org/W65134806","doi":"https://doi.org/10.1111/j.1464-410x.2011.10124.x","mag":"65134806","pmid":"https://pubmed.ncbi.nlm.nih.gov/21332630"},"language":"en","primary_location":{"id":"doi:10.1111/j.1464-410x.2011.10124.x","doi":"https://doi.org/10.1111/j.1464-410x.2011.10124.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1464-410x.2011.10124.x","pdf_url":null,"source":{"id":"https://openalex.org/S191188855","display_name":"British Journal of Urology","issn_l":"1464-4096","issn":["1464-4096","1464-410X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BJU International","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W65134806"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049019006","display_name":"Claus G. Roehrborn","orcid":"https://orcid.org/0000-0003-4024-7369","observed_orcids":["https://orcid.org/0000-0003-4024-7369"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["CA","US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Claus G. Roehrborn","raw_affiliation_strings":["Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA. claus.roehrborn@UTSouthwestern.edu","Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, Department of Urology, University of Toronto, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA. claus.roehrborn@UTSouthwestern.edu","institution_ids":["https://openalex.org/I867280407"]},{"raw_affiliation_string":"Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, Department of Urology, University of Toronto, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073537684","display_name":"Jack Barkin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["CA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jack Barkin","raw_affiliation_strings":["Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, Department of Urology, University of Toronto, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, Department of Urology, University of Toronto, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045201891","display_name":"Paul F. Siami","orcid":"https://orcid.org/0000-0002-7915-9692","observed_orcids":["https://orcid.org/0000-0002-7915-9692"]},"institutions":[{"id":"https://openalex.org/I4210097048","display_name":"Deaconess Clinic","ror":"https://ror.org/00z9bse70","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210097048"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul Siami","raw_affiliation_strings":["Deaconess Clinic, Evansville, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Deaconess Clinic, Evansville, IN","institution_ids":["https://openalex.org/I4210097048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061191487","display_name":"Andrea Tubaro","orcid":"https://orcid.org/0000-0002-1682-2493","observed_orcids":["https://orcid.org/0000-0002-1682-2493"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andrea Tubaro","raw_affiliation_strings":["Department of Urology, \u2018La Sapienza\u2019 University, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, \u2018La Sapienza\u2019 University, Rome, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102145563","display_name":"Timothy H. Wilson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Timothy H. Wilson","raw_affiliation_strings":["GlaxoSmithKline, Research Triangle Park, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015571667","display_name":"Betsy B. Morrill","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Betsy B. Morrill","raw_affiliation_strings":["GlaxoSmithKline, Research Triangle Park, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, NC, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059324891","display_name":"R. Paul Gagnier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. Paul Gagnier","raw_affiliation_strings":["GlaxoSmithKline, Research Triangle Park, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, NC, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5049019006"],"corresponding_institution_ids":["https://openalex.org/I185261750","https://openalex.org/I867280407"],"apc_list":{"value":4770,"currency":"USD","value_usd":4770},"apc_paid":null,"fwci":11.849,"has_fulltext":false,"cited_by_count":126,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.98928062,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"107","issue":"6","first_page":"946","last_page":"954"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benign-prostatic-hyperplasia","display_name":"benign prostatic hyperplasia","score":0.996999979019165},{"id":"https://openalex.org/keywords/dutasteride","display_name":"dutasteride","score":0.9860000014305115},{"id":"https://openalex.org/keywords/tamsulosin","display_name":"tamsulosin","score":1.0},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9710000157356262},{"id":"https://openalex.org/keywords/acute-urinary-retention","display_name":"acute urinary retention","score":0.8309999704360962},{"id":"https://openalex.org/keywords/clinical-progression","display_name":"clinical progression","score":0.7400000095367432},{"id":"https://openalex.org/keywords/lower-urinary-tract-symptoms","display_name":"lower urinary tract symptoms","score":0.925000011920929},{"id":"https://openalex.org/keywords/baseline-predictors","display_name":"baseline predictors","score":0.4740000069141388},{"id":"https://openalex.org/keywords/prostate-volume","display_name":"prostate volume","score":0.5370000004768372},{"id":"https://openalex.org/keywords/prostate-specific-antigen","display_name":"prostate-specific antigen","score":0.9319999814033508},{"id":"https://openalex.org/keywords/maximum-urinary-flow-rate","display_name":"maximum urinary flow rate","score":0.906000018119812},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.8489999771118164},{"id":"https://openalex.org/keywords/5alpha-reductase-inhibitors","display_name":"5-alpha reductase inhibitors","score":0.9139999747276306},{"id":"https://openalex.org/keywords/alpha-blockers","display_name":"alpha-blockers","score":0.9169999957084656},{"id":"https://openalex.org/keywords/post-hoc-analysis","display_name":"post hoc analysis","score":0.5199999809265137},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.44600000977516174}],"concepts":[{"id":"https://openalex.org/C2780542891","wikidata":"https://www.wikidata.org/wiki/Q418480","display_name":"Tamsulosin","level":3,"score":0.9510338306427002},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9108376502990723},{"id":"https://openalex.org/C2778878792","wikidata":"https://www.wikidata.org/wiki/Q424760","display_name":"Dutasteride","level":4,"score":0.836187481880188},{"id":"https://openalex.org/C2776547966","wikidata":"https://www.wikidata.org/wiki/Q1283551","display_name":"International Prostate Symptom Score","level":5,"score":0.7617874145507812},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.7604057788848877},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5435351133346558},{"id":"https://openalex.org/C2779478474","wikidata":"https://www.wikidata.org/wiki/Q446372","display_name":"Lower urinary tract symptoms","level":4,"score":0.5330492258071899},{"id":"https://openalex.org/C2779091618","wikidata":"https://www.wikidata.org/wiki/Q1366695","display_name":"Urinary retention","level":2,"score":0.5050860047340393},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.4730455279350281},{"id":"https://openalex.org/C2780435053","wikidata":"https://www.wikidata.org/wiki/Q506659","display_name":"Benign prostatic hyperplasia (BPH)","level":4,"score":0.4560714364051819},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4319611191749573},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.42391350865364075},{"id":"https://openalex.org/C2777562237","wikidata":"https://www.wikidata.org/wiki/Q835051","display_name":"Hyperplasia","level":2,"score":0.4233092665672302},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3718298077583313},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3660135269165039},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000068538","descriptor_name":"Dutasteride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077409","descriptor_name":"Tamsulosin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001378","descriptor_name":"Azasteroids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D004812","descriptor_name":"Epidemiologic Methods","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011470","descriptor_name":"Prostatic Hyperplasia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D011470","descriptor_name":"Prostatic Hyperplasia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011470","descriptor_name":"Prostatic Hyperplasia","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016055","descriptor_name":"Urinary Retention","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016055","descriptor_name":"Urinary Retention","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D016055","descriptor_name":"Urinary Retention","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058891","descriptor_name":"5-alpha Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1464-410x.2011.10124.x","doi":"https://doi.org/10.1111/j.1464-410x.2011.10124.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1464-410x.2011.10124.x","pdf_url":null,"source":{"id":"https://openalex.org/S191188855","display_name":"British Journal of Urology","issn_l":"1464-4096","issn":["1464-4096","1464-410X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BJU International","raw_type":"journal-article"},{"id":"pmid:21332630","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21332630","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BJU international","raw_type":"Journal Article"},{"id":"pmh:oai:iris.uniroma1.it:11573/415706","doi":null,"is_oa":false,"landing_page_url":"http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000288212700016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=0c7ff228ccbaaa74236f48834a34396a","pdf_url":null,"source":{"id":"https://openalex.org/S4377196107","display_name":"IRIS Research product catalog (Sapienza University of Rome)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1964370987","https://openalex.org/W1974345369","https://openalex.org/W1979870734","https://openalex.org/W1982951328","https://openalex.org/W2010616721","https://openalex.org/W2011962188","https://openalex.org/W2017065464","https://openalex.org/W2018009871","https://openalex.org/W2024659096","https://openalex.org/W2026635055","https://openalex.org/W2027189010","https://openalex.org/W2030698665","https://openalex.org/W2042565581","https://openalex.org/W2061191313","https://openalex.org/W2066674875","https://openalex.org/W2076846229","https://openalex.org/W2081313560","https://openalex.org/W2081597080","https://openalex.org/W2121759271","https://openalex.org/W2122930170","https://openalex.org/W2126104986","https://openalex.org/W2129362053","https://openalex.org/W2157948398","https://openalex.org/W2165635016","https://openalex.org/W2804551733","https://openalex.org/W2907622422","https://openalex.org/W4236163484","https://openalex.org/W4299485640"],"related_works":["https://openalex.org/W2081597080","https://openalex.org/W2026635055","https://openalex.org/W1972077267","https://openalex.org/W2153780696","https://openalex.org/W2079340088","https://openalex.org/W2083605121","https://openalex.org/W2088502605","https://openalex.org/W1581876684","https://openalex.org/W1580447354","https://openalex.org/W2105070451"],"abstract_inverted_index":{"What\u2019s":[0],"known":[1],"on":[2,18,110,142,292,584,591],"the":[3,8,37,51,77,88,98,105,111,137,143,265,293,315,332,365,400,455,481,508,565,576,598],"subject?":[4],"and":[5,24,31,41,58,79,83,117,156,180,215,218,260,288,304,387,469,536,553,572,581,614],"What":[6],"does":[7],"study":[9,34,90,96,183,190],"add?":[10],"Treatment":[11],"of":[12,29,39,54,72,100,104,107,113,139,146,169,178,191,212,223,239,258,264,267,275,295,302,329,334,367,374,383,402,413,419,423,449,459,491,501,510,533,550,558,567,578,601],"benign":[13,151],"prostatic":[14,152],"hyperplasia":[15,153],"(BPH)":[16],"centres":[17],"two":[19],"drug":[20],"classes,":[21],"5\u03b1\u2010reductase":[22],"inhibitors":[23],"\u03b1\u2010blockers.":[25],"The":[26,175,242,421],"4\u2010year":[27,144,176],"Combination":[28,177],"Avodart\u00ae":[30,179],"Tamsulosin":[32,181],"(CombAT)":[33,182],"investigated":[35],"whether":[36],"combination":[38,128,168,238],"dutasteride":[40,233,351,434,472,539,588,605],"tamsulosin":[42,230,345,362,432,464,515,592,607],"was":[43,184,245,339,358,405,426,480,524],"more":[44],"effective":[45],"than":[46,346,361,433,590],"either":[47],"monotherapy":[48,589],"in":[49,62,121,160,194,314,341,347,363,372,380,407,429,438,486,495,540,564,575,608],"reducing":[50,364],"relative":[52,456],"risk":[53,71,366,457],"AUR,":[55,114],"BPH\u2010related":[56,115,251,298,337,370,570],"surgery,":[57,116,299],"BPH":[59,259,612],"clinical":[60,119,158,192,256,300,403,424,460,579],"progression":[61,120,159,257,301,404,425,461,484,580],"men":[63,161,195,313,342,408,430,444,497,528,609],"with":[64,124,130,163,199,207,344,350,409,445,463,471,498,514,529,538,546,604,610],"moderate\u2010to\u2010severe":[65,611],"LUTS":[66],"who":[67],"were":[68,306,311,321],"at":[69,503],"increased":[70],"disease":[73],"progression.":[74],"Data":[75],"from":[76],"2\u2010":[78],"4\u2010year,":[80],"pre\u2010planned":[81],"primary":[82,243],"secondary":[84],"endpoint":[85,244],"analyses":[86,103,263,596],"for":[87,443,527],"CombAT":[89],"have":[91],"been":[92],"reported":[93],"previously.":[94],"This":[95],"reports":[97],"outcomes":[99,193],"post":[101],"hoc":[102],"influence":[106,138,266],"baseline":[108,140,268,319,330,375,384,390,411,440,447,467,475,492,520,531,548,555],"parameters":[109],"incidence":[112,145,294,333,401,422],"overall":[118,157],"patients":[122,228],"treated":[123,162,343,349],"tamsulosin,":[125,164],"dutasteride,":[126,165],"or":[127,166,236,250,297,336,352,369,415,435,569,587],"therapy":[129,357,437,453,506,586,603],"both":[131],"agents.":[132],"OBJECTIVE":[133],"\u2022":[134,174,226,241,309,327,355,396,477,544,594],"To":[135],"investigate":[136],"variables":[141,269],"acute":[147],"urinary":[148,282],"retention":[149],"(AUR),":[150],"(BPH)\u2010related":[154],"surgery":[155,338,371,571],"a":[167,185,219,237,410,446,530,547,615],"both.":[170,240],"PATIENTS":[171],"AND":[172],"METHODS":[173],"multicenter,":[186],"randomized,":[187],"double\u2010blind,":[188],"parallel\u2010group":[189],"aged":[196],"\u226550":[197],"years":[198],"symptomatic":[200],"(International":[201],"Prostate":[202],"Symptom":[203,478],"Score":[204],"[IPSS]\u226512)":[205],"BPH,":[206,303],"prostate\u2010specific":[208],"antigen":[209],"(PSA)":[210],"levels":[211],"\u22651.5":[213,559],"ng/mL":[214,560],"\u226410":[216],"ng/mL,":[217],"prostate":[220],"volume":[221],"(PV)":[222],"\u226530":[224],"mL.":[225,451],"Eligible":[227],"received":[229],"0.4":[231],"mg,":[232,235],"0.5":[234],"time":[246],"to":[247],"first":[248],"AUR":[249,296,335,368,568],"surgery.":[252],"Secondary":[253],"endpoints":[254],"included":[255],"symptoms.":[261],"Posthoc":[262],"(including":[270],"age,":[271],"IPSS":[272,412,416,500],"health\u2010related":[273],"quality":[274],"life":[276],"[HRQL],":[277],"PV,":[278],"PSA,":[279],"IPSS,":[280],"peak":[281],"flow":[283],"rate":[284],"[Q":[285],"max":[286],"]":[287],"body\u2010mass":[289],"index":[290],"[BMI])":[291],"symptoms":[305,613],"performed.":[307],"RESULTS":[308],"There":[310],"4844":[312],"intent\u2010to\u2010treat":[316],"population.":[317],"Overall":[318],"characteristics":[320],"similar":[322],"across":[323,465,473,516],"all":[324,381,388,439,466,517],"patient":[325],"groups.":[326],"Regardless":[328],"subgroup,":[331,493],"higher":[340,428],"those":[348,496],"combined":[353,436,585,602],"therapy.":[354],"Combined":[356,452,505],"statistically":[359],"better":[360],"subgroups":[373,382,391,468],"PV":[376,448,532,549],">":[377],"42.0":[378],"mL,":[379],"PSA":[385,556],"level,":[386],"other":[389],"(":[392],"P":[393],"\u2264":[394],"0.001).":[395],"Across":[397],"treatment":[398,488],"groups,":[399],"highest":[406],"<20":[414],"HRQL":[417],"score":[418],"<4.":[420],"also":[427],"receiving":[431],"subgroups,":[441],"except":[442,494],"<40":[450,534],"reduced":[454,507],"(RR)":[458],"compared":[462,470,513,537],"most":[474,482,541],"subgroups.":[476,542],"deterioration":[479,512,583],"common":[483],"event":[485],"each":[487],"group":[489],"regardless":[490],"an":[499],"\u226520":[502],"baseline.":[504],"RR":[509,566,577],"symptom":[511,582],"but":[518],"one":[519],"subgroup":[521],"(the":[522],"reduction":[523],"not":[525],"significant":[526],"mL)":[535],"CONCLUSIONS":[543],"Men":[545],"\u226540":[551],"mL":[552],"any":[554],"level":[557],"had":[561],"greater":[562,573],"reductions":[563,574],"monotherapy.":[593],"These":[595],"support":[597],"long\u2010term":[599],"use":[600],"plus":[606],"slightly":[616],"enlarged":[617],"prostate.":[618]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W65134806","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":18},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
